found deletions of IKZF1 to occur in ~20% of AML cases that arose secondary to myeloproliferative neoplasms suggesting a differential role of deletions and mutations in myeloid leukemogenesis (64). The gene discussed is IKZF1; the disease is myeloproliferative neoplasm.